Approval · Notice of Compliance 27558 · 2022
ESTRACE: Notice of Compliance 27558
Issued February 9, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27558
- Date
- February 9, 2022
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESTRACE | Not yet assigned | — |